📞Call us
+91 80629 16290
Amrutanjan Health Care Ltd.
₹538.2
3.6 (0.7%)
AMRUTANJAN Share Price
As on July 17, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 1,555 Cr
P/E Ratio76.46
Dividend Yield0.36 %
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open536.7
High538.7
NSE SymbolAMRUTANJAN
Close538.2
Low531
BSE Symbol590006
Previous Years High/Low
1 Year High790.95
3 Year High862.6
5 Year High1,024.55
1 Year Low486
3 Year Low486
5 Year Low486
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 536.67 | Bullish |
| 10-DMA | 536.46 | Bullish |
| 20-DMA | 540.26 | Bearish |
| 50-DMA | 549.6 | Bearish |
| 100-DMA | 551.49 | Bearish |
| 200-DMA | 612.17 | Bearish |
Historical Performance
1 Year
-23.2%
3 Years
-21.6%
5 Years
-23.8%
10 Years
153.6%
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2016 |
|---|---|
| Net Sales | 1,867 |
| Total Expenditure | 1,560 |
| Other Income | 57 |
| Operating Profit | 365 |
| Interest | 4 |
| Depreciation | 33 |
| Profit Before Tax | 327 |
| Consolidated Net Profit | 206 |
| Adjusted EPS | 7 |
Compounded Sales Growth
10 Years:0
5 Years:0
3 Years:0
TTM:0
Compounded Profit Growth
10 Years:0
5 Years:0
3 Years:0
TTM:0
Stock Price CAGR
10 Years:9.7
5 Years:-4.9
3 Years:-7.9
TTM:-22.1
Return on Equity
10 Years:1.8
5 Years:3.3
3 Years:4.3
last year:7
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2016 |
|---|---|
| Share Capital | 29 |
| Total Reserves | 1,058 |
| Long-Term Borrowings | --- |
| Total Non-Current Liabilities | 37 |
| Other Current Liabilities | 144 |
| Short Term Borrowings | 25 |
| Total Liabilities | 1,404 |
| Capital Work in Progress | 7 |
| Long Term Loans & Advances | 13 |
| Currents Investments | --- |
| Short Term Loans and Advances | 121 |
| Total Current Assets | 1,005 |
| Total Assets | 1,404 |
| Adjusted Book Value | 37 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 76.46, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered a weak 3-year price CAGR of -7.9%, indicating poor shareholder returns.
- The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹365 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹1867 million, suggesting a mid-sized operation.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 775448.5
No. of Shares: 1441 (Approx)
Performance:-22.5%
-224551.5
NIFTY Performance: -2.5%
1 day Top Gainers
| Symbol | Change% |
|---|---|
| ECLERX | 1979.8(13%) |
| AIIL | 571(10%) |
| FEDERALBNK | 349(7%) |
| KALYANKJIL | 574.4(5%) |
| AFCONS | 299.75(5%) |
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
